Kalalahti, Inari http://orcid.org/0000-0002-7368-1850
Huotari, Kaisa
Erickson, Andrew. M.
Petas, Anssi
Vasarainen, Hanna
Rannikko, Antti
Funding for this research was provided by:
K. Albin Johanssons Stiftelse (Awarded in 2020)
Juhani Ahon Lääketieteen Tutkimussäätiö (Awarded in 2021)
Suomen Syöpärekisteri
Jane ja Aatos Erkon Säätiö
University of Helsinki including Helsinki University Central Hospital
Article History
Received: 2 May 2022
Accepted: 9 July 2022
First Online: 5 August 2022
Declarations
:
: I Kalalahti reports personal grants from K. Albin Johansson foundation in 2020 and from the Juhani Aho Foundation for Medical Research in 2021. A Rannikko reports grants from State Research Funding (VTR), Finnish Cancer Organizations and Jane and Aatos Erkko Foundation. K Huotari, AM Erickson, A Petas and H Vasarainen have nothing to declare.
: The use of registry data was approved by the Helsinki University Hospital (HUS) institutional board (HUS/333/2019).
: Due to the retrospective study design, informed consent was waived, and the participants were not contacted.